Novo Nordisk to cut 9,000 jobs: Ozempic maker to reduce workforce by 11%; refocus on diabetes and obesity treatments
Novo Nordisk is set to reduce its workforce by 11%, eliminating 9,000 jobs globally, including 5,000 in Denmark, to save $1.3 billion amid rising competition for its obesity treatments. This restructuring follows a lowered earnings forecast and aims to streamline operations for growth in diabetes and obesity markets. Shares rose despite the announcement.🕒 1 min read
Novo Nordisk is set to reduce its workforce by 11%, eliminating 9,000 jobs globally, including 5,000 in Denmark, to save $1.3 billion amid rising competition for its obesity treatments. This restructuring follows a lowered earnings forecast and aims to streamline operations for growth in diabetes and obesity markets. Shares rose despite the announcement.
Continue Reading
- Robocalls set to clock Rs 5,300 crore loans for Bajaj Finance in FY26
- Desi B-schools make gains in QS rankings, but challenges remain
- Asia Cup: After Bronco, a new drill introduced to test Indian cricketers in Dubai
-
Canadian Mother Sues OpenAI, Says ChatGPT Encouraged Daughter’s Suicide
-
Outback Steakhouse Sued After Toilet Seat Collapse Leaves US Man With “Serious Bodily Injury”
- How To Make Coca Cola At Home: Viral Video Shows The Recipe
- CM Rekha Gupta Attacked LIVE Updates: Police Registers Case Of Attempt To Murder After Attack On Rekha Gupta
-
“No Wrong Words”: Shimla Doctor Speaks Out On Fight With Patient Over ‘Tu’
-
Pope Leo XIV Calls For “Sufficient Humanitarian Aid” Into Gaza, End Hostilities
-
Army Details How 6 Terrorists Were Eliminated In 2 Encounters In J&K